MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, Wales, UK.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Transl Psychiatry. 2017 Sep 26;7(9):e1241. doi: 10.1038/tp.2017.212.
Severe irritability is one of the commonest reasons prompting referral to mental health services. It is frequently seen in neurodevelopmental disorders that manifest early in development, especially attention-deficit/hyperactivity disorder (ADHD). However, irritability can also be conceptualized as a mood problem because of its links with anxiety/depressive disorders; notably DSM-5 currently classifies severe, childhood-onset irritability as a mood disorder. Investigations into the genetic nature of irritability are lacking although twin studies suggest it shares genetic risks with both ADHD and depression. We investigated the genetic underpinnings of irritability using a molecular genetic approach, testing the hypothesis that early irritability (in childhood/adolescence) is associated with genetic risk for ADHD, as indexed by polygenic risk scores (PRS). As a secondary aim we investigated associations between irritability and PRS for major depressive disorder (MDD). Three UK samples were utilized: two longitudinal population-based cohorts with irritability data from childhood (7 years) to adolescence (15-16 years), and one ADHD patient sample (6-18 years). Irritability was defined using parent reports. PRS were derived from large genome-wide association meta-analyses. We observed associations between ADHD PRS and early irritability in our clinical ADHD sample and one of the population samples. This suggests that early irritability traits share genetic risk with ADHD in the general population and are a marker of higher genetic loading in individuals with an ADHD diagnosis. Associations with MDD PRS were not observed. This suggests that early-onset irritability could be conceptualized as a neurodevelopmental difficulty, behaving more like disorders such as ADHD than mood disorders.
严重的易怒是促使人们寻求心理健康服务的最常见原因之一。它经常出现在神经发育障碍中,这些障碍在发育早期就表现出来,尤其是注意缺陷/多动障碍(ADHD)。然而,由于与焦虑/抑郁障碍有关,易怒也可以被视为一种情绪问题;值得注意的是,DSM-5 目前将严重的、儿童期起病的易怒归类为一种情绪障碍。尽管双胞胎研究表明,易怒与 ADHD 和抑郁症都有共同的遗传风险,但对其遗传本质的研究仍然缺乏。我们使用分子遗传学方法研究了易怒的遗传基础,检验了以下假设:即早期易怒(儿童期/青春期)与 ADHD 的遗传风险有关,这可以通过多基因风险评分(PRS)来衡量。作为次要目标,我们研究了易怒与 PRS 之间的关联,PRS 是用于衡量 major depressive disorder(MDD)的遗传风险。我们利用了三个英国样本:两个具有从儿童期(7 岁)到青春期(15-16 岁)的易怒数据的纵向人群队列,以及一个 ADHD 患者样本(6-18 岁)。易怒是通过家长报告来定义的。PRS 是从大型全基因组关联荟萃分析中得出的。我们在我们的临床 ADHD 样本和一个人群样本中观察到 ADHD PRS 与早期易怒之间存在关联。这表明,在普通人群中,早期易怒特征与 ADHD 存在共同的遗传风险,并且是 ADHD 患者遗传负荷较高的标志物。与 MDD PRS 之间没有观察到关联。这表明,早期发作的易怒可能被视为一种神经发育障碍,与 ADHD 等障碍更相似,而不是与情绪障碍更相似。